HCPCS Code Descriptor:
Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries
Route of Administration:
ZEVALIN is a Radiopharmaceutical drug manufactured by Ceft Biopharma and administered via the Intravenous route of administration. The A Code: A9543 is aligned to the drug ZEVALIN.